|
Ongoing research projects
|
Approval date
|
|
O uso de um índice de comorbilidades para prever a resposta clínica em doentes com artrite reumatoide tratados com o seu primeiro agente biológico -
view (Portuguese only)
|
08-08-2020
|
|
Effectiveness and safety of original and biosimilar etanercept (Enbrel vs Benepali) in bDMARD-naïve patients in a real-world cohort of Portugal -
view
|
20-07-2020
|
|
Demographic and clinical features of Portuguese Patients with Systemic Sclerosis: a Nationwide Multicenter Cohort Study -
view
|
10-07-2020
|
|
Clinical course and predictors of severe COVID-19 among patients with rheumatic diseases in Portugal – a multicentre, nationwide study -
view
|
14-06-2020
|
|
Há diferenças clínicas atribuíveis ao sexo nas espondilartrites axiais? -
view (Portuguese only)
|
2020-03-05
|
|
Pulmonary Hypertension in systemic sclerosis: data from Reuma.pt -
view
|
2019-10-26
|
|
Registro Brasil & Portugal de vasculites sistêmicas -
view (Portuguese only)
|
2019-10-23
|
|
Frequency of disease-associated autoantibodies in Reuma.pt systemic sclerosis cohort patients and its association with characteristic clinical features -
view
|
2019-10-10
|
|
PROSAS STUDY – Persistence, Effectiveness and Real-World Outcomes in SpondylArthritis patients treated with Secukinumab -
view
|
2019-04-07
|
|
PREDICT - Personalized therapy for RhEumatic DIseases via machine learning -
view
|
2019-03-21
|
|
Determinants of happiness and quality of life in people with systemic sclerosis: a structural equation modelling approach -
view
|
2019-01-18
|
|
Demyelinating diseases in patients treated with tumor necrosis factor inhibitors for rheumatic diseases -
view
|
2018-11-19
|
|
Early retirement attributed to Rheumatoid Arthritis and its predictors -
view
|
2018-11-14
|
|
Safety and effectiveness of biologic Disease-Modifying Antirheumatic Drugs in elderly patients
with rheumatoid arthritis -
view
|
2018-10-27
|
|
Efficacy and Safety of Belimumab in the treatment of Systemic Lupus Erythematosus: a Prospective Multicenter Study -
view
|
2018-09-13
|
|
Remission and low disease activity matrix tool: results in real- world Rheumatoid Arthritis patients under golimumab -
view
|
2018-09-10
|
|
Predictive factors of relapse, in patients with JIA in remission, after discontinuation of disease-modifying antirheumatic drugs -
view
|
2018-08-15
|
|
Effectiveness, safety, quality of life, costs and persistence of biosimilar etanercept compared to reference etanercept in juvenile idiopathic arthritis patients – data from the Portuguese register Reuma.pt -
view
|
2018-06-29
|
|
"PRO Reuma Initiative": collecting patient-reported outcomes using touchscreen technology -
view
|
2018-06-17
|
|
Comparing disease features and outcomes in patients with membranous and proliferative lupus nephritis -
view
|
2018-06-16
|
|
Juvenile idiopathic arthritis in Portugal and Brazil: a comparative study -
view
|
2018-06-09
|
|
Impact of the implementation of biosimilars in the treatment of different rheumatic diseases perceived by the patients and by society (repercussion in Patient Reported Outcomes and economic costs) -
view
|
2018-06-08
|
|
Variation in patient-reported outcomes for patients with Inflammatory Rheumatic diseases: evidence from Portugal -
view
|
2018-05-16
|
|
Validation of Juvenile Spondyloarthritis Disease Activity Index (JSPADA) in a prospective cohort of Portuguese patients with juvenile spondyloarthritis -
view
|
2018-04-29
|
|
Autoinflammatory Diseases: analysis based on The Rheumatic Diseases Portuguese Register -
view
|
2018-04-25
|
|
Mapping from the Ankylosing Spondylitis Disease Activity Score (ASDAS) to EQ5D in patients with Axial Spondyloarthritis (axSpA) -
view
|
2018-04-12
|
|
Neoplasms and systemic inflammatory rheumatic diseases -
view (Portuguese only)
|
2018-03-18
|
|
Predictors of skin score change in systemic sclerosis: a Reuma.pt analysis -
view
|
2018-03-18
|
|
Comparative long-term effectiveness and safety of switching to alternative tumour necrosis factor antagonists, tocilizumab or rituximab in patients with rheumatoid arthritis and inadequate response to a first-line TNF inhibitor -
view
|
2017-10-06
|
|
Pattern of drug use in systemic lupus erythematosus and reasons for drug discontinuation in real life clinical practice -
view
|
2017-07-07
|
|
Biological therapy in women with immune-mediated inflammatory rheumatic diseases: influence on pregnancy outcomes -
view
|
2017-06-19
|
|
Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis: is the reason to switch relevant? -
view
|
2017-04-19
|
|
Adult outcomes of Juvenile Idiopathic Arthritis -
view
|
2017-02-04
|
|
Efficacy and safety of biosimilar infliximab CT-P13 compared to originator infliximab in rheumatoid arthritis and axial spondyloarthritis patients -
view
|
2017-01-19
|
|
Eligibility criteria for TNFi therapy in axSpA: BASDAI vs ASDAS -
view
|
2016-09-15
|
|
RAID - The potential role of the "Rheumatoid Arthritis Impact of Disease" score in the management of RA -
view
|
2016-02-02
|
|
Portuguese Early Arthritis Cohort -
view (Portuguese only)
|
2015-05-14
|
|
Biologics discontinuation in RA and SpA : Retrospective analysis of reasons for discontinuation and outcome -
view
|
2015-03-25
|
|
Tuberculosis risk and prevention in Rheumatic Patients Treated with Biological Therapy -
view
|
2014-04-06
|
|
Influence of Body Mass Index in Response to Biologic therapy in Rheumatoid Arthritis -
view
|
2014-01-03
|